Hong Kong Archives | Page 2 of 12 | Be Korea-savvy
Digital Entertainment Leadership Forum Officially Opens Today

Digital Entertainment Leadership Forum Officially Opens Today

HONG KONG SAR, Dec. 15 (Korea Bizwire) - The grand opening of the annual Digital Entertainment Leadership Forum (DELF) took place at Cyberport today, with Zhang Zhihua, Director General of the Youth Department of the Liaison Office of the Central People’s Government in the Hong Kong Special Administrative Region (HKSAR), Dr David Chung, JP, Under Secretary for [...]

President of the Chinese Culture and Arts Association Comments on Electoral System Amendments: Improve Hong Kong’s Ability to “Govern Itself”

President of the Chinese Culture and Arts Association Comments on Electoral System Amendments: Improve Hong Kong’s Ability to “Govern Itself”

HONG KONG, March 17 (Korea Bizwire) — China’s top legislature endorsed on Thursday a decision on improving the electoral system of the Hong Kong Special Administrative Region, which marks another major step to improve the region’s legal and political systems, said Lv Jian-she, President of the Hong Kong-based Chinese Culture and Arts Association. The plan [...]

Cyberport Houses Over 30 InsurTech Start-ups with Great Potential

Cyberport Houses Over 30 InsurTech Start-ups with Great Potential

Hong Kong, Aug. 11 (Korea Bizwire) — As a key promoter of Hong Kong’s digital technologydevelopments, Hong Kong Cyberport spares no efforts in injecting new momentum into theeconomy. Cyberport has the largest FinTech community in Hong Kong, boosting close to400 FinTech companies that offer financial software and services, financial data analysis,wealth management technology, payment technology [...]

Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEX

Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEX

SHANGHAI, China, July 12 (Korea Bizwire) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong Limited (HKEX) pursuant to Rule 18A.12 of the Rules Governing the Listing of Securities on HKEX [...]